Top Markets
#1 MowCat MowCat +48.89%
#2 Bermuda Shorts Bermuda Shorts +30.33%
#3 aPriori aPriori +22.89%
#4 Derive Derive +19.95%
#5 Velvet Velvet +19.35%
#6 Biconomy Biconomy +19.15%
#7 Audiera Audiera +18.63%
#8 Quack AI Quack AI +16.83%
#9 Perle Perle +13.71%
#10 Block Street Block Street +11.88%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Mustang Bio, Inc. Mustang Bio, Inc.

Mustang Bio, Inc.

MBIO
Clasificación en acciones #35075
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on... Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Precio por acción
$0.594
Última sincronización: 2026-08-14
Capitalización bursátil
$4.50M
Cambio (1 día)
0.00%
Cambio (1 año)
-66.44%
País
US
Comercio Mustang Bio, Inc. (MBIO)

Categoría

Healthcare
Historial del precio de la acción de Mustang Bio, Inc. (MBIO)
Precio más alto de cierre: $0.60 el 2026-08-01

Precio más bajo de cierre: $8.92K el 2017-08-01
Historial del precio de la acción de Mustang Bio, Inc. desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -10.26%
2025 -87.55%
2024 -86.83%
2023 -76.52%
2022 -79.00%
2021 -45.05%
2020 -1.99%
2019 18.38%
2018 -73.75%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE